GLP-3

GLP-3 (LY3437943) is an investigational synthetic peptide developed as a triple receptor agonist targeting the GLP-1, GIP, and glucagon (GCG) receptors. This multi-receptor signaling profile has made GLP-3 a significant focus within modern metabolic and energy-regulation research models. Within laboratory environments, GLP-3 has been investigated in studies involving metabolic signaling, energy expenditure, glucose regulation, lipid metabolism, mitochondrial activity, and body composition pathways. Researchers have explored its potential involvement in appetite-regulation signaling, insulin sensitivity models, hepatic fat metabolism, and broader metabolic pathway research. Unlike earlier single-pathway incretin compounds, GLP-3 combines GLP-1 and GIP receptor activity with glucagon receptor signaling, allowing researchers to investigate multiple interconnected metabolic mechanisms simultaneously. This integrated signaling profile has positioned GLP-3 as a widely recognised compound within contemporary metabolic and mitochondrial research environments. Manufactured to strict research-grade standards, each batch undergoes independent full-panel analytical verification through ISO 17025 accredited laboratories for purity, identity, sterility, and consistency.